Acasti Pharma Short Interest Ratio and Short Volume

+0.02 (+0.92 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume416,900 shs
Average Volume2.74 million shs
Market Capitalization$57.05 million
P/E RatioN/A
Dividend YieldN/A

Acasti Pharma (NASDAQ:ACST) Short Interest Data

Current Short Volume408,500 shares
Previous Short Volume3,060,000 shares
Change Vs. Previous Month-86.65%
Dollar Volume Sold Short$1.09 million
Short Interest Ratio / Days to Cover0.3
Last Record DateAugust, 31 2021
Outstanding Shares26,050,000 shares
Float Size40,230,000 shares
Short Percent of Float1.02%
Today's Trading Volume416,900 shares
Average Trading Volume2,742,672 shares
Today's Volume Vs. Average-84.80%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Acasti Pharma ?

Sign up to receive the latest short interest report for Acasti Pharma and its competitors with MarketBeat's FREE newsletter.

Acasti Pharma (NASDAQ:ACST) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2021408,500 shares $1.09 million -86.7%1.0%0.3 $2.67
8/13/20213,060,000 shares $1.38 million +21.9%1.5%0.3 $0.45
7/30/20212,510,000 shares $1.15 million -9.7%1.2%0.2 $0.46
7/15/20212,780,000 shares $1.47 million -11.8%1.4%0.2 $0.53
6/30/20213,150,000 shares $1.77 million -0.6%1.5%0.2 $0.56
6/15/20213,170,000 shares $1.66 million -31.2%1.5%0.2 $0.53
5/28/20214,610,000 shares $2.30 million +5.7%2.2%0.4 $0.50
5/14/20214,360,000 shares $1.89 million +10.4%2.1%0.3 $0.43
4/30/20213,950,000 shares $1.96 million +32.6%1.9%0.2 $0.50
4/15/20212,980,000 shares $1.39 million -0.7%1.5%0.1 $0.47
3/31/20213,000,000 shares $1.77 million -16.2%1.5%0.1 $0.59
3/15/20213,580,000 shares $2.59 million +169.2%1.8%0.1 $0.72
2/26/20211,330,000 shares $1.02 million -25.3%0.7%0 $0.77
2/12/20211,780,000 shares $1.98 million -20.5%1.0%0 $1.11
1/29/20212,240,000 shares $1.56 million +40.9%1.3%0.1 $0.69
1/15/20211,590,000 shares $1.01 million +428.2%1.7%0 $0.63
12/31/2020301,000 shares $107,607.50 -40.6%0.3%0 $0.36
12/15/2020506,800 shares $126,750.68 -40.7%0.5%0 $0.25
11/30/2020854,400 shares $215,906.88 +57.2%0.9%0.1 $0.25
11/15/2020543,500 shares $113,156.70 +18.9%0.6%0.1 $0.21
10/30/2020457,100 shares $86,666.16 -75.2%0.5%0.1 $0.19
10/15/20201,840,000 shares $397,992.00 +34.3%2.0%0.3 $0.22
9/30/20201,370,000 shares $274,274.00 +25.7%1.5%0.2 $0.20
9/15/20201,090,000 shares $218,000.00 +141.3%1.2%0.2 $0.20
8/31/2020451,800 shares $110,555.46 +87.9%0.5%0.1 $0.24

Acasti Pharma (NASDAQ:ACST) Short Interest FAQ

speech bubbles
speech bubbles

What is Acasti Pharma's current short interest?

Short interest is the volume of Acasti Pharma shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 408,500 shares of ACST short. 1.02% of Acasti Pharma's shares are currently sold short. Learn More on Acasti Pharma's current short interest.

What is a good short interest percentage for Acasti Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.02% of Acasti Pharma's floating shares are currently sold short.

Is Acasti Pharma's short interest increasing or decreasing?

Acasti Pharma saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 408,500 shares, a decrease of 86.7% from the previous total of 3,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acasti Pharma's float size?

Acasti Pharma currently has issued a total of 26,050,000 shares. Some of Acasti Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acasti Pharma currently has a public float of 40,230,000 shares.

How does Acasti Pharma's short interest compare to its competitors?

1.02% of Acasti Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acasti Pharma: Alzamend Neuro, Inc. (1.36%), Corvus Pharmaceuticals, Inc. (1.81%), Clever Leaves Holdings Inc. (0.00%), Trevena, Inc. (9.38%), Larimar Therapeutics, Inc. (2.91%), Tonix Pharmaceuticals Holding Corp. (0.00%), Tricida, Inc. (6.78%), Oncternal Therapeutics, Inc. (4.51%), 180 Life Sciences Corp. (0.00%), and Decibel Therapeutics, Inc. (5.37%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Acasti Pharma stock?

Short selling ACST is an investing strategy that aims to generate trading profit from Acasti Pharma as its price is falling. Acasti Pharma's stock is trading up $0.02 today. To short Acasti Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Acasti Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acasti Pharma?

A short squeeze for Acasti Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACST, which in turn drives the price of the stock up even further.

How often is Acasti Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACST, twice per month. The most recent reporting period available is August, 31 2021.

This page was last updated on 9/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.